InfoBionic Ai
InfoBionic.Ai is a US digital health company offering the FDA-cleared MoMe ARC platform for AI-enabled remote cardiac monitoring, serving cardiology practices, hospitals, and health systems through hardware plus recurring subscription services.
- Company typePrivate
- Founded2012
- HeadquartersChelmsford, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What InfoBionic Ai does
InfoBionic.Ai is a US-based digital health company founded in 2011 and headquartered in Chelmsford, Massachusetts, that develops and commercializes the MoMe ARC® platform for AI-enabled remote cardiac monitoring. The platform provides continuous 6-lead FDA-cleared ECG monitoring via interchangeable biosensor leads, a 4G LTE gateway device, a single-lead adhesive patch, and a cloud-based analytics layer (MoMe.net) that applies FDA-cleared AI algorithms for multi-class arrhythmia detection with reported accuracy above 99% in controlled datasets. The company holds ISO 13485 certification, HIPAA Business Associate status, SOC 2 Type 2, and HITRUST CSF r2 compliance, and is protected by at least 17 issued US patents covering ECG monitoring methods, data transmission, and device configurations.
The company operates a direct enterprise go-to-market targeting cardiology practices, hospitals, and health systems, with named customers including Mayo Clinic, Marple Medical Associates, South Orange County Cardiology, Cardiology Consultants of Philadelphia, Capital Cardiology Associates, Carient Heart & Vascular, and Sparrow Hospital. GTM combines enterprise field sales and inside sales with marketing support via content, PR, events, and podcasts. Distribution channels include direct sales and inclusion in the Epic Showroom Connection Hub, plus a GSA Schedule (19:036F79721D0248) for federal healthcare facilities.
Revenue is generated through a combination of hardware sales (MoMe Sensors, MoMe Gateway, MoMe ARC Patch) and recurring subscription/services on the MoMe ARC platform under monthly billing, with quote-based enterprise pricing. The company has raised approximately $23M+ across disclosed rounds ($8M in 2015, up to $15M in 2020, Series D in January 2024) and has executed a series of strategic partnerships in 2024-2025 including Mayo Clinic, Anumana, HBox.ai, Epic Systems, and Trace3 to extend its AI and ecosystem capabilities.
InfoBionic Ai firmographics
Firmographics- Name
- InfoBionic Ai
- Legal name
- InfoBionic, LLC
- Website
- https://infobionic.ai
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- InfoBionic.Ai is a US digital health company offering the FDA-cleared MoMe ARC platform for AI-enabled remote cardiac monitoring, serving cardiology practices, hospitals, and health systems through hardware plus recurring subscription services.
- Ownership category
- akta.pro rank
Where InfoBionic Ai is headquartered
LocationHeadquarters
- HQ city
- Chelmsford
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
InfoBionic Ai business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure, Personnel, Operations
Revenue model
- MoMe ARC Platform Subscription/Services: The company generates revenue through recurring subscription fees for its MoMe ARC virtual cardiac telemetry platform, which includes software access, AI-enabled analytics, and cloud-based data management services. The platform is provided to healthcare provider customers as a HIPAA Business Associate.
- Hardware Sales (Sensors, Gateway, Patch): InfoBionic.Ai sells hardware components including MoMe Sensors, MoMe Gateway devices, and MoMe ARC Patch products. These are physical medical devices that work in conjunction with the software platform for remote cardiac monitoring.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Quote-based enterprise pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
InfoBionic Ai product offering
Product offeringCore offering
InfoBionic.Ai develops and sells the MoMe ARC platform, an FDA-cleared AI-enabled remote cardiac monitoring system that provides continuous 6-lead ECG capture, wireless biosensor data transmission, and cloud-based AI analytics for arrhythmia detection. The offering pairs the MoMe ARC software platform with complementary hardware (MoMe Sensors, MoMe Gateway, MoMe ARC Patch) sold primarily to cardiology practices, hospitals, and health systems in the United States.
Product overview
InfoBionic.Ai offers the MoMe ARC® platform, a comprehensive AI-enabled remote cardiac monitoring system for virtual cardiac telemetry. The portfolio includes the core MoMe ARC® platform (the first continuous 6-lead FDA-cleared virtual cardiac telemetry system), paired with complementary modules: MoMe Sensors (interchangeable biosensor lead sets providing hospital-grade 6-lead ECG), MoMe ARC® Patch (FDA-cleared single-lead adhesive patch for extended wear), MoMe Gateway® (4G LTE connectivity device for data transmission), and MoMe Solutions (AI-powered analytics with EHR integration). The MoMe.net cloud platform provides FDA-cleared AI algorithm-informed arrhythmia detection. Together, these products enable configurable hospital-grade monitoring from nearly anywhere, supporting the full spectrum of patient acuity levels.
Differentiator
Problem solved
Functional benefit
Products and services
- MoMe ARC® The flagship virtual cardiac telemetry platform providing AI-enabled remote cardiac ECG monitoring with continuous 6-lead hospital-grade monitoring capability powered by advanced AI analysis; recognized as the gold standard in remote cardiac care.
- MoMe Sensors Interchangeable and tiered biosensor lead sets that can be tailored to each patient's level of acuity, with a 3-electrode sensor providing hospital-grade 6-lead ECG data review.
- MoMe ARC® Patch A lightweight, adhesive single-lead patch designed for extended wear and effortless use without sacrificing data quality, integrating with the MoMe ARC platform.
- MoMe Gateway®
- MoMe Solutions AI-enabled analytics platform that processes data from the MoMe ARC system, providing full-disclosure ECG analysis, seamless EHR integration, HIPAA-compliant cloud interface, and AI-assisted analytics for immediate cardiac insight.
Quantifiable outcome
- AI arrhythmia detection accuracy above 99% in controlled test datasets
- +3 more outcomes
Companies that use InfoBionic Ai
Customer profileNamed customers10 records
Segments8 records
Ideal customer profiles3 records
InfoBionic Ai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature7 records
InfoBionic Ai partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Epic SystemscoreInfoBionic.Ai announced inclusion of its MoMe ARC solution in Connection Hub on Epic Showroom, making the remote cardiac monitoring platform readily available to the thousands of hospitals and clinics using Epic EHR systems. This integration enables seamless workflow for Epic users.
- AnumanacoreAnumana, an AI-driven health technology company and portfolio company of nference, announced collaboration with InfoBionic.Ai to advance AI-powered remote cardiac telemetry technology for early detection of cardiac diseases. The partnership focuses on leveraging Anumana's AI capabilities with InfoBionic's remote monitoring platform to improve cardiac disease detection.
- HBox.aicoreInfoBionic.Ai and HBox.ai partnered to create the first comprehensive cardiovascular care solution for the 'Cardiology Clinic of the Future.' This collaboration integrates HBox.ai's virtual care model with InfoBionic.Ai's MoMe ARC platform to deliver a complete AI-driven virtual cardiology solution.
- Cardiology Consultants of PhiladelphiaminorCardiology Consultants of Philadelphia (CCP) and InfoBionic.Ai partnered for a featured appearance on 'Health Uncensored' with Dr. Drew Pinsky, with electrophysiologist Dr. Colin Movsowitz representing CCP alongside InfoBionic's technology.
- Mayo CliniccoreInfoBionic entered into a know-how agreement with Mayo Clinic to enhance its remote patient monitoring platform. Mayo Clinic's Cardiac Monitoring Service collaborated with InfoBionic to advance the technology. In January 2024, they furthered their partnership to enhance the MoMe platform for remote patient monitoring.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
InfoBionic Ai competitors and assessment
Company assessmentDirect peers
- Biotricity: Biotricity is a small-cap digital health company offering remote cardiac monitoring solutions (e.g., Bioflux) directly comparable to MoMe ARC in use case, customer base, and SaaS-style recurring model.
- AliveCor: AliveCor's KardiaMobile is a consumer-and-clinic ECG and arrhythmia detection device with FDA-cleared AI algorithms, competing in the same cardiac monitoring and AI arrhythmia detection category from a more consumer-leaning angle.
- Bardy Diagnostics (Baxter): BardyDx's CAM (Cardiac Ambulatory Monitor) patch competed directly in AI-enabled extended-wear cardiac monitoring before its acquisition by Baxter; it is a relevant reference peer for InfoBionic.Ai's patch strategy.
- iRhythm Technologies: iRhythm's Zio long-term continuous cardiac monitoring patch is a direct competitor to InfoBionic.Ai's MoMe ARC, both offering AI-enabled ambulatory ECG monitoring for arrhythmia detection to cardiology customers.
- Cardiac Insight: Cardiac Insight offers the Cardea SOLO wearable ECG sensor and AI-based arrhythmia analysis, a closely comparable ambulatory cardiac monitoring platform for cardiology and primary care customers.
- Boston Scientific (Preventice Solutions): Boston Scientific acquired Preventice, a direct competitor in AI-enabled remote cardiac monitoring with body-worn sensors and telemetry services, making it a large medtech peer with overlapping product and customer base.
Broad incumbents
- GE HealthCare: GE HealthCare sells hospital-grade patient monitoring systems and is investing in AI-enabled cardiology diagnostics, making it a broad incumbent with overlapping hospital cardiac monitoring customers.
- Hillrom / Baxter (cardiac monitoring): Hillrom, now part of Baxter, provides a range of cardiac and patient monitoring solutions to hospitals and ambulatory providers, making it a broad incumbent with enterprise relationships that overlap with InfoBionic.Ai's hospital targets.
- Philips (BioTelemetry / Cardiac Care): Philips owns BioTelemetry, a major ambulatory cardiac monitoring service, giving it overlapping remote cardiac telemetry capabilities as part of a much broader connected care and hospital portfolio.
Emerging players
- Eko Health: Eko Health combines digital stethoscopes with AI-powered cardiac and pulmonary disease detection; it overlaps with InfoBionic.Ai in AI ECG analysis and clinician-facing cardiac diagnostics, but with a distinct device form factor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
InfoBionic Ai social profiles
Digital presenceInfoBionic Ai compliance and trust
Trust signalCompliance4 records
InfoBionic Ai financial estimates
Financial estimateRevenue estimate
Valuation estimate
InfoBionic Ai leadership team
Management profileNumber of profiles
Profiles3 records
InfoBionic Ai funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InfoBionic Ai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InfoBionic Ai
What does InfoBionic Ai do?
InfoBionic.Ai develops and sells the MoMe ARC platform, an FDA-cleared AI-enabled remote cardiac monitoring system that provides continuous 6-lead ECG capture, wireless biosensor data transmission, and cloud-based AI analytics for arrhythmia detection. The offering pairs the MoMe ARC software platform with complementary hardware (MoMe Sensors, MoMe Gateway, MoMe ARC Patch) sold primarily to cardiology practices, hospitals, and health systems in the United States.
Is InfoBionic Ai a public or private company?
InfoBionic Ai is a private company. It is classified as venture growth investor backed and is currently operating.
When was InfoBionic Ai founded?
InfoBionic Ai was founded in 2012. It employs 11 to 50 people.
Where is InfoBionic Ai based?
InfoBionic Ai is headquartered in Chelmsford, United States, in the North America region.
How does InfoBionic Ai make money?
Two revenue lines are on record. MoMe ARC Platform Subscription/Services are the primary driver. The others are hardware Sales (Sensors, Gateway, Patch).
Who are InfoBionic Ai's main competitors?
Direct peers on record are Biotricity, AliveCor, Bardy Diagnostics (Baxter), iRhythm Technologies, Cardiac Insight and Boston Scientific (Preventice Solutions). Broad incumbents are GE HealthCare, Hillrom / Baxter (cardiac monitoring) and Philips (BioTelemetry / Cardiac Care). Eko Health is listed as an emerging player.
Does InfoBionic Ai have an API?
No public API is recorded for InfoBionic Ai.